TLOG News Alert Tetralogic Pharmaceuticals Corp (TLOG) 4.45 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tetralogic Pharmaceuticals Corp (TLOG) 4.45 $TLOG

TetraLogic Announces Initiation of a Randomized Phase 2 Clinical Trial of SHAPE in Subjects With Cutaneous T-Cell Lymphoma
GlobeNewswire - Thu Dec 18, 6:00AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced the initiation of a randomized Phase 2 clinical trial of SHAPE in subjects with early stage cutaneous T-cell lymphoma ("CTCL" .
TLOG: 4.45 (-0.09)

Market Maker Surveillance Report. JRJC, ECSL, TLOG, WLDN, HGSH, EKSO, Losing Stocks With Lowest Price Friction For Tuesday, December 16th 2014
M2 - Wed Dec 17, 2:18AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5122 companies with "abnormal" market making, 2762 companies with positive Friction Factors and 4010 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. China Finance Online Co Ltd (NASDAQ:JRJC), ECARE SOLUTIONS INC (OTC:ECSL), TRANSFORM LOGIC CORP (NASDAQ:TLOG), Willdan Group Inc (NASDAQ:WLDN), China Hgs Real Estate Inc (NASDAQ:HGSH), (OTC:EKSO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
JRJC: 5.81 (-0.11), HGSH: 4.60 (-0.06), TLOG: 4.45 (-0.09), WLDN: 12.77 (+0.45)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 16, 11:47AM CST

FRO: 2.43 (-0.01), TLM: 7.84 (unch), ECR: 6.98 (+0.09), BBX: 16.67 (-0.07), WG: 6.07 (-0.13), HGSH: 4.60 (-0.06), NVGN: 2.40 (-0.09), TPLM: 5.74 (-0.41), TLOG: 4.45 (-0.09), CYCC: 0.69 (+0.01), SFY: 4.47 (-0.06), BBG: 11.46 (-0.24), WRES: 1.66 (-0.13), GOL: 5.16 (-0.04), NAV: 33.81 (-0.11), WYY: 1.33 (-0.03), FNJN: 2.46 (+0.18), LINE: 10.93 (-0.32), SCX: 19.06 (+0.12), WLDN: 12.77 (+0.45)

TetraLogic Provides Update on Ovarian Cancer Study
GlobeNewswire - Tue Dec 16, 6:00AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it intends to proceed with the expansion phase of its study in patients with ovarian cancer. The study is being conducted in patients who have failed up to three rounds of prior chemotherapy. In the study birinapant has been dosed twice weekly, 3 weeks out of 4, or 4 weeks out of 4, in combination with Amgen's TRAIL receptor 2 agonist antibody, conatumumab, dosed every 2 weeks. Patients are scanned for disease status after every 8 weeks (2 cycles).
AMGN: 160.67 (+3.15), TLOG: 4.45 (-0.09)

TetraLogic Pharma perking up
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 9:23AM CST

TLOG: 4.45 (-0.09)

TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 56th Annual American Society of Hematology Annual Meeting
GlobeNewswire - Thu Dec 04, 6:29AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that two abstracts related to clinical data on birinapant will be presented at the 56 Annual American Society of Hematology meeting to be held in San Francisco from December 6-9, 2014.
TLOG: 4.45 (-0.09)

TetraLogic to Participate in Two Conferences in December
GlobeNewswire - Tue Dec 02, 6:30AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that company management will participate in the following conferences in New York this month:
TLOG: 4.45 (-0.09)

Andrew L. Pecora of TetraLogic Pharmaceuticals Corporation (TLOG)-NasdaqGM bought Shares of TLOG
M2 - Thu Nov 20, 7:06AM CST
Reported by InsiderCow.com at 2014-11-19 12:36:34 ET
TLOG: 4.45 (-0.09)

TetraLogic Pharmaceuticals Announces Results of Preclinical Studies in Hepatitis B
GlobeNewswire - Mon Nov 10, 7:42AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced additional results from preclinical studies that demonstrated the ability of the SMAC-mimetic, birinapant, to clear Hepatitis B Virus (HBV) in mouse models.
TLOG: 4.45 (-0.09)

TetraLogic Pharmaceuticals Announces Appointment of Mary Ann Gray, Ph.D. and Mr. Michael D. Kishbauch as New Directors
GlobeNewswire - Fri Nov 07, 10:10AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced the appointment of Mary Ann Gray, Ph.D. and Mr. Michael D. Kishbauch as Class I directors to fill two board slots that have been vacant since January 2014.
TLOG: 4.45 (-0.09)

TetraLogic misses by $0.08
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:25PM CST

TLOG: 4.45 (-0.09)

TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update
GlobeNewswire - Wed Nov 05, 3:38PM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases, today announced financial results for the third quarter ended September 30, 2014. These results are included in TetraLogic's Quarterly Report on Form 10-Q which has been filed with the Securities and Exchange Commission.
AMGN: 160.67 (+3.15), TLOG: 4.45 (-0.09)

TetraLogic Pharmaceuticals to Host Investor Forum on November 10, 2014
GlobeNewswire - Mon Nov 03, 6:30AM CST
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that the company will host a live audio webcast in conjunction with its Investor Forum during the 2014 American Association for the Study of Liver Diseases Meeting on Monday, November 10, 2014 at 7:30 a.m. Eastern Time in Boston, MA.
TLOG: 4.45 (-0.09)

TetraLogic Pharmaceuticals to Present Data From Pre-Clinical Studies With Hepatitis B at the 2014 International Meeting on Molecular Biology of Hepatitis B Viruses
GlobeNewswire - Wed Aug 27, 6:39AM CDT
TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that data from the preclinical studies that provide the rationale for SMAC-mimetics as a potential therapy for Hepatitis B will be presented at the 2014 International Meeting on Molecular Biology of Hepatitis B Viruses to be held in Los Angeles at UCLA from September 3-6, 2014.
TLOG: 4.45 (-0.09)

4 Stocks Under $10 Making Big Moves
at The Street - Fri Aug 08, 6:22AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
TXMD: 4.25 (-0.10), OGXI: 2.10 (-0.04), HIMX: 8.07 (+0.06), TLOG: 4.45 (-0.09)

Can the Rally in TetraLogic (TLOG) Shares Continue?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 23

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 104

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Protein Now! Gains Clinician Attention, With Caveats

Updated Category News Views 91

A Small Bottle Has Drawn a Crowd Protein powder tubs have been cluttering kitchens for years; a 3.38-fluid-ounce shot is a cleaner answer to the same daily hassle. NutraBio Labs says more than 800 physicians, nurse practitioners, and physician associates had added PROTEIN NOW! to their individual FrontrowMD patient pages as of November 2026. That earned the product a...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 14

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 75

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading

Top 5 Most Recently Viewed Articles

ICG Enterprise Trust plc Announces Share Repurchase Details

Updated Category News Views 159

ICG Enterprise Trust plc Share Buyback Announcement ICG Enterprise Trust plc (the “Company”) The Company has announced a recent development regarding its share buyback initiative. On a significant date, it repurchased 15,000 of its own shares aimed to be held as treasury shares, with each share valued at an average price of 1450 pence. Details of the Transaction...

Continue Reading
Converge Technology Solutions Shares Third Quarter 2024 Insights

Updated Category News Views 217

Converge Technology Solutions Announces Preliminary Q3 Results Converge Technology Solutions Corp. (CTS) has released its preliminary unaudited financial results for the third quarter of 2024. The company is committed to delivering insightful updates to its stakeholders as part of its transparency approach. The company stated that all figures are presented in Canadian...

Continue Reading
Discovery Silver Corp. Unveils 2023 ESG Report

Updated Category News Views 104

Discovery Silver Corp. Releases 2023 ESG Report Key Highlights: Earned Quality Environmental Certification from the Mexican Government Recognized as a Socially Responsible Enterprise by the Mexican Center for Philanthropy Achieved Great Place to Work Certification Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) is excited to announce the publication of its 2023...

Continue Reading
Final Call for Subscription in IDEX Biometrics Offering Today

Updated Category News Views 152

Important Subscription Period Details for IDEX Biometrics Today marks a significant turning point for IDEX Biometrics ASA as the subscription period for their subsequent offering of shares closes. The company previously announced that they aim to issue up to 600 million new shares at a remarkable subscription price of NOK 0.01 per share. This offering, essential for...

Continue Reading
Dundee Corporation Strengthens Position in Greenheart Gold Inc.

Updated Category News Views 33

Overview of Recent Acquisition Dundee Corporation (TSX: DC.A) has announced that its wholly-owned subsidiary, Dundee Resources Limited, recently acquired 2,000,000 common shares of Greenheart Gold Inc. (TSXV: GHRT) at a price of C$0.50 per share, totaling an investment of C$1,000,000. This acquisition is part of the Issuer's bought deal private placement and signifies...

Continue Reading